Patients "desperate for therapy" would be denied potential treatment if Britain outlaws human-animal embryos, scientists said.
By proposing to prohibit the fusion of human DNA with animal eggs, scientists said ministers are barring access to a powerful medical research tool, The Times of London said Friday. The technique produces embryos that are 99.5 percent human and is aimed to address the shortage of human eggs for stem cell research.
The proposal was released last month. It won't become law for at least a year, but scientists said it already affected research. Two groups wanting to use the technique applied to the Human Fertilization and Embryology Authority for licenses, which are expected to be denied.
British Public Health Minister Caroline Flint said the decision followed public consultation in which most participants opposed the technique. Scientists said only 535 commented.
"There are hundreds of thousands of patients in Britain with degenerative neurological conditions," Chris Shaw, King's College London, who is researching motor neuron disease, told The Times. "We can use these cell lines to study them, and to see if drugs are going to be effective. To shut that down is a real affront to patients who are desperate for therapy."
Copyright 2007 by United Press International
Related stories:
Age of earliest human burial in Britain pinpointed
The oldest known buried remains in Britain are 29,000 years old, archaeologists have found – 4,000 years older than previously thought. The findings show that ceremonial burials were taking place in western Europe much earlier than researchers had believed.
Scientists peel away the mystery behind gold's catalytic prowess
Few materials have exercised as much of a hold on the human imagination, or on human history, as has gold. But for all of its popular uses – money, medals, jewelry and more – gold's potential as a catalyst lay hidden until the 1980s, when Masatake Haruta and Graham Hutchings independently discovered that gold, which had long been considered inactive, could be an extraordinarily good catalyst. Haruta demonstrated the low-temperature oxidation of CO and Hutchings the hydrochlorination of acetylene to vinyl chloride.
New nano device detects immune system cell signaling
Scientists have detected previously unnoticed chemical signals that individual cells in the immune system use to communicate with each other over short distances.
A sharper look at malaria
(PhysOrg.com) -- In work that could lead to new ways of detecting and treating malaria, MIT researchers have used two advanced microscopy techniques to show in unprecedented detail how the malaria parasite attacks red blood cells.
Suicide risks studied in drugs for physical ills
(AP) -- Cody Miller was a high school football player who was allergic to ragweed. Douglas Briggs was a doctor coping with pain from an old back injury. Both are now dead, hanging victims driven to suicide, their families believe, when drugs prescribed to relieve physical symptoms upset their mental and emotional balance. Federal drug regulators are investigating to see if the families could be right.
New approach, old drug show promise against hepatitis C, research shows
The fight against the liver disease hepatitis C has been at something of an impasse for years, with more than 150 million people currently infected, and traditional antiviral treatments causing nasty side effects and often falling short of a cure. Using a novel technique, medical and engineering researchers at Stanford University have discovered a vulnerable step in the virus' reproduction process that in lab testing could be effectively targeted with an obsolete antihistamine.
Landmark study opens door to new cancer, aging treatments
Researchers at The Wistar Institute have deciphered the structure of the active region of telomerase, an enzyme that plays a major role in the development of nearly all human cancers. The landmark achievement opens the door to the creation of new, broadly effective cancer drugs, as well as anti-aging therapies.
Scientists examine bird flu infections to monitor for 'pandemic' mutations
Scientists funded by the Wellcome Trust are to examine what is preventing the H5N1 avian influenza virus from causing a human pandemic and what mutations are required to realise its deadly potential. The research could hold the key to early identification of a potential influenza pandemic, and to developing drugs and a vaccine.